Earnings Call Summary | NeuroOne Medical(NMTC.US) Q2 2024 Earnings Conference
The following is a summary of the NeuroOne Medical Technologies Corporation (NMTC) Q2 2024 Earnings Call Transcript:Financial Performance:NeuroOne reported a significant growth in Q2 product revenue o
NeuroOne Medical Technologies Corporation (NMTC) Q2 2024 Earnings Call Transcript
NeuroOne Medical Technologies Corporation (NMTC) Q2 2024 Earnings Call Transcript
NeuroOne Medical | 10-Q: Quarterly report
NeuroOne Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate...
NeuroOne Medical Tech 2Q Rev $1.38M >NMTC
NeuroOne Medical Tech 2Q Rev $1.38M >NMTC
NeuroOne to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14
EDEN PRAIRIE, Minn., May 10, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgic
NeuroOne CEO Dave Rosa Featured on Bloomberg Technology
EDEN PRAIRIE, Minn., April 10, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and
NeuroOne Announces First Implant of OneRF Ablation Electrodes
First to market FDA-cleared thin-film, sEEG-guided RF system capable of both recording electrical activity and ablating nervous tissue with the added benefit of temperature control EDEN PRAIRIE, Minn., April 09, 2024
NeuroOne CEO Dave Rosa Featured on Fox Business Network's Varney & Co.
EDEN PRAIRIE, Minn., April 04, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surg
NeuroOne Initiates Limited Commercial Launch of OneRF Ablation System
First to market FDA-cleared thin-film, sEEG-guided RF system capable of both recording electrical activity and ablating nervous tissue with the added benefit of temperature control Limited commercial launch
NeuroOne Medical Advances With Key Shareholder Decisions
12 Health Care Stocks Moving In Monday's Intraday Session
GainersRegencell Bioscience (NASDAQ:RGC) shares rose 130.9% to $10.39 during Monday's regular session. The company's market cap stands at $135.2 million. TC BioPharm (Holdings) (NASDAQ:TCBP) shares in
NeuroOne to Participate in the 36th Annual Roth Conference
EDEN PRAIRIE, Minn., March 08, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical
NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
EDEN PRAIRIE, Minn., Feb. 23, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical
DTSS, TNON and BREA Among Mid-day Movers
12 Health Care Stocks Moving In Wednesday's Intraday Session
GainersCogent Biosciences (NASDAQ:COGT) stock increased by 64.0% to $8.96 during Wednesday's regular session. The company's market cap stands at $771.2 million. Larimar Therapeutics (NASDAQ:LRMR) shar
Q1 2024 Neuroone Medical Technologies Corp Earnings Call
Earnings Call Summary | NeuroOne Medical(NMTC.US) Q1 2024 Earnings Conference
The following is a summary of the NeuroOne Medical Technologies Corporation (NMTC) Q1 2024 Earnings Call Transcript:Financial Performance:NeuroOne reported a product revenue of $978,000 in Q1 2024, a
NeuroOne Medical Tech Q1 2024 GAAP EPS $(0.14), Inline, Sales $977.65K Beat $852.00K Estimate
NeuroOne Medical Tech (NASDAQ:NMTC) reported quarterly losses of $(0.14) per share which met the analyst consensus estimate. The company reported quarterly sales of $977.65 thousand which beat the an
NeuroOne Medical Tech 1Q Loss/Shr 14c >NMTC
NeuroOne Medical Tech 1Q Loss/Shr 14c >NMTC